Core Viewpoint - The company emphasizes its commitment to social responsibility, aiming for sustainable development while balancing economic benefits with the interests of various stakeholders, including shareholders, creditors, employees, customers, suppliers, and the community [1][2]. Group 1: General Principles - The company establishes a social responsibility system to align with national laws and regulations, promoting comprehensive development and environmental protection [1]. - Social responsibility encompasses obligations to various stakeholders, including the protection of shareholder interests and engagement in environmental and public welfare initiatives [1]. Group 2: Protection of Shareholder and Creditor Rights - The company is committed to enhancing its governance structure and ensuring fair treatment of all shareholders, providing them with legal rights [2]. - It will implement a stable profit distribution policy and ensure financial health while considering the interests of creditors [2][3]. Group 3: Employee Rights Protection - The company adheres to labor laws, ensuring the protection of employee rights and promoting a harmonious labor relationship [5][6]. - It will establish a fair compensation system and provide a safe working environment, while also respecting employees' personal rights [5][6]. Group 4: Protection of Suppliers, Customers, and Consumers - The company commits to honesty and integrity in dealings with suppliers, customers, and consumers, ensuring product safety and addressing complaints effectively [16][17]. - It will maintain confidentiality of supplier and customer information and prevent commercial bribery [21][22]. Group 5: Environmental Protection and Sustainable Development - The company aims to integrate environmental protection into its development strategy, complying with relevant laws and promoting energy efficiency [23][24]. - It will establish an environmental management system and report on its environmental impact and sustainability efforts [25][26]. Group 6: Public Relations and Social Welfare - The company will engage with the community and participate in social welfare activities, contributing to local economic development [30][31]. - It aims to create job opportunities, particularly for rural laborers, and enhance product quality through innovation [33][34]. Group 7: System Construction and Information Disclosure - The board of directors will regularly evaluate the implementation of the social responsibility system and publish a social responsibility report alongside the annual report [35][36]. - The report will address issues related to employee protection, environmental pollution, and community relations [36].

Core Viewpoint - The document outlines the management system for related party transactions of Tianshui Zhongxing Mushroom Industry Technology Co., Ltd, ensuring fairness, transparency, and compliance with relevant laws and regulations [1][2][3]. Group 1: General Principles - The related party transactions must adhere to principles of equality, voluntariness, equivalence, and compensation [1][2]. - Transactions should be documented in written agreements that clarify the rights, obligations, and legal responsibilities of both parties [1][2]. - Related parties with voting rights at shareholder meetings must abstain from voting on related transaction matters [1][2]. Group 2: Definition and Scope of Related Parties - Related parties include both legal entities and natural persons that have significant control or ownership over the company [2][3]. - Legal entities that control the company directly or indirectly, or hold more than 5% of the company's shares, are considered related parties [2][3]. Group 3: Transaction Pricing and Management - The pricing of related party transactions should follow a hierarchy: state pricing, market price, cost-plus pricing, and negotiated pricing [10][11]. - Transactions must be settled monthly based on the agreed price and actual transaction quantity [11]. Group 4: Decision-Making Procedures and Disclosure - Transactions exceeding certain thresholds must be approved by a majority of independent directors and disclosed to the board [12][13]. - Transactions with amounts exceeding 30,000 yuan with natural persons or 3 million yuan with legal entities must be disclosed [12][13]. Group 5: Supervision and Compliance - The audit committee is responsible for overseeing related party transactions [35]. - Internal audit departments must conduct quarterly checks on the implementation of related transactions and report findings to the board [36][37]. Group 6: Miscellaneous Provisions - The document specifies that related party transactions must not harm the interests of the company and minority shareholders [10][19]. - The management system will take effect upon approval by the company's shareholders [42].

天水众兴菌业科技股份有限公司 天水众兴菌业科技股份有限公司 天水众兴菌业科技股份有限公司 对外担保管理制度 甘肃·天水 二○二五年八月 天水众兴菌业科技股份有限公司 对外担保管理制度 （以下简称《公司法》）、 《中华人民共和国证券法》（以下简称《证券法》）、《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要求》、《深圳证券交易所股票上市 规则》、《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》等法律、法规、规范性文件及《公司章程》的有关规定，结合公司实际， 制定本制度。 第二条 本制度所称对外担保是指公司为他人提供的担保，包括公司对控股 子公司的担保。公司以第三人的身份为债务人对于债权人所负的债务提供担保， 当债务人不履行债务时，由公司按照约定履行债务或者承担责任的行为，包括但 不限于公司以自有资产和/或信用为其他单位和个人提供的保证、资产抵押、质 押以及其他担保事宜，具体包括但不限于申请银行信用额度担保、银行借款担保、 银行开立信用证和银行承兑汇票担保、开具保函的担保等。 第三条 本制度所称控股子公司是指公司出资设立的全资子公司、公司持股 比例超过 50%的子公司和 ...

Core Viewpoint - The company plans to issue a maximum of RMB 500 million in technology innovation bonds to enhance its financing channels, reduce costs, and optimize its debt structure in response to national policies on technological innovation [1][2] Group 1: Bond Issuance Details - The company will apply to the China Interbank Market Dealers Association for the registration and issuance of the bonds, with the issuance amount not exceeding RMB 500 million [1] - The issuance will be subject to market conditions and will involve qualified investors as per regulatory requirements [1] Group 2: Authorization and Management - The board of directors seeks authorization from the shareholders' meeting to allow the management team to make decisions regarding the bond issuance, including terms such as scale, duration, interest rates, and repayment methods [1] - The board will also have the authority to adjust the issuance plan based on regulatory changes and market conditions [2] Group 3: Impact of Bond Issuance - Successful issuance of the bonds is expected to diversify financing channels, improve cash flow, enhance liquidity management, and provide stable funding support for the company's strategic development [1] - The issuance aligns with the interests of the company and all shareholders, ensuring no harm to minority shareholders [1]

Core Viewpoint - The company reported a significant increase in net profit for the first half of 2025, despite a slight decline in revenue compared to the same period last year. Financial Performance - Operating revenue for the reporting period was CNY 907,845,326.28, a decrease of 0.75% from CNY 914,678,822.16 in the same period last year [1] - Net profit attributable to shareholders was CNY 69,019,917.47, representing a 134.13% increase from CNY 29,478,836.92 [1] - Net profit after deducting non-recurring gains and losses was not specified [1] - Net cash flow from operating activities was CNY 150,489,987.90, down 16.76% from CNY 180,800,164.60 [1] - Basic earnings per share increased to CNY 0.1840 from CNY 0.0750, a rise of 145.33% [1] - Diluted earnings per share also increased to CNY 0.1840 from CNY 0.0750, a rise of 145.33% [1] - The weighted average return on equity was 2.07%, up from 0.86%, an increase of 1.21% [1] Asset and Equity Status - Total assets at the end of the reporting period were CNY 6,477,146,674.05, an increase of 4.62% from CNY 6,190,908,422.74 [3] - Net assets attributable to shareholders were CNY 3,256,160,032.19, a decrease of 1.84% from CNY 3,317,126,129.96 [3] Shareholder Information - The total number of shareholders at the end of the reporting period was 33,443 [3] - Major shareholders include: - Tao Jun: 28.01% (110,136,094 shares) [3] - Tian De: 7.92% (31,132,277 shares) [3] - Other significant shareholders include various entities and individuals with smaller percentages [3] Important Events - The company plans to provide guarantees not exceeding CNY 1,970 million for certain subsidiaries [5] - A total investment of CNY 122.52 million is planned for the transformation of a production line [6] - The company has completed a share buyback of 18,498,826 shares, accounting for 4.7042% of total shares, with a total expenditure of CNY 142,973,058.63 [7] - A cash dividend of CNY 3.00 per 10 shares was approved for distribution to shareholders [8] - The controlling shareholder has pledged 62,310,000 shares, representing 44.11% of their holdings and 15.85% of the company's total shares [9]

Core Viewpoint - Tianshui Zhongxing Bio-technology Co., Ltd. reported a slight decrease in revenue but a significant increase in net profit for the first half of 2025, indicating improved profitability despite a challenging revenue environment [2][3]. Company Overview and Financial Indicators - The company operates in the agricultural sector, focusing on the research, cultivation, and sales of edible and medicinal fungi [3][5]. - Key financial metrics for the first half of 2025 include: - Revenue: CNY 907.85 million, a decrease of 0.75% from CNY 914.68 million in the same period last year [2][15]. - Net profit attributable to shareholders: CNY 69.02 million, an increase of 134.13% from CNY 29.48 million [2][15]. - Basic earnings per share: CNY 0.184, up 145.33% from CNY 0.075 [2][15]. - Total assets: CNY 6.48 billion, an increase of 4.62% from CNY 6.19 billion [2][15]. Business Operations - The company primarily engages in the cultivation of edible mushrooms, with a focus on Jinzheng mushrooms and double-capped mushrooms [5][6]. - The company has diversified its operations by exploring the cultivation of rare medicinal fungi, including a project for the industrialized cultivation of Cordyceps [4][5]. - The company has established production bases across several provinces, including Gansu, Shaanxi, Shandong, and Jiangsu, enhancing its operational footprint [5][12]. Sales and Revenue Composition - The revenue breakdown for the first half of 2025 shows: - Jinzheng mushrooms: CNY 320.65 million, accounting for 35.32% of total revenue, down 15.98% year-on-year [16]. - Double-capped mushrooms: CNY 572.30 million, representing 63.04% of total revenue, up 9.10% year-on-year [16]. - The company also reported revenue from rental business, which increased significantly by 111.79% [16]. Market and Competitive Position - The company benefits from a well-distributed production base, particularly in regions with abundant agricultural by-products, which helps reduce raw material costs [12][13]. - The company employs a factory-based production model that allows for year-round production, ensuring a stable supply of high-quality products [7][13]. - The company has received various certifications, including ISO 9001:2015 and HACCP, which enhance its credibility and product quality assurance [13][14]. Future Outlook - The company is actively pursuing diversification strategies, including the establishment of a southwestern headquarters for the edible and medicinal fungi industry, focusing on the cultivation of Cordyceps [4][5]. - The ongoing projects may face uncertainties related to policy changes, market conditions, and operational risks, which could impact future profitability [4][5].

第五届监事会第九次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 天水众兴菌业科技股份有限公司（以下简称"公司"）第五届监事会第九次 会议于 2025 年 08 月 15 日在公司会议室以通讯方式召开。召开本次会议的通知 已于 2025 年 08 月 04 日以电子邮件方式送达各位监事。 本次会议由监事会主席张天荣先生主持，会议应出席监事 3 名，实际出席 3 名。会议召开程序符合《公司法》和《公司章程》等的有关规定。 二、监事会会议审议情况 证券代码：002772 证券简称：众兴菌业 公告编号：2025-045 天水众兴菌业科技股份有限公司 经与会监事认真审议，本次会议以记名投票表决方式表决通过了以下议案： （一）审议通过了《关于公司<2025 年半年度报告全文及摘要>的议案》 监事会认为：董事会编制和审核公司《2025 年半年度报告》的程序符合法 律、行政法规和中国证监会的规定，报告内容真实、准确、完整地反映了公司的 实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。同意通过该报告并 签署了书面确认意见。 表决情况 ...

证券日报网讯 8月15日晚间，众兴菌业发布公告称，公司董事会同意公司拟向中国银行间市场交易商协 会申请注册发行最高不超过人民币5亿元（含5亿元）科技创新债券。 （文章来源：证券日报） ...

格隆汇8月15日丨众兴菌业(002772.SZ)公布，为积极响应国家科技创新政策导向，加大科技创新投入力 度，同时进一步拓宽融资渠道、降低融资成本并优化债务结构，公司董事会同意公司拟向中国银行间市 场交易商协会申请注册发行最高不超过人民币5亿元（含5亿元）科技创新债券。 ...

格隆汇8月15日丨众兴菌业(002772.SZ)公布半年度报告，营业收入9.08亿元，同比下降0.75%，归属于上 市公司股东的净利润6901.99万元，同比增长134.13%，归属于上市公司股东的扣除非经常性损益的净利 润5440.77万元，同比增长166.06%。 ...